Victory Capital Management’s AnaptysBio ANAB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6M	Sell	108,203 -2,380	-2%	-$128K	﹤0.01%	1260
2025 Q4	$5.36M	Sell	110,583 -93,472	-46%	-$3.64M	﹤0.01%	1288
2025 Q3	$6.25M	Sell	204,055 -328,030	-62%	-$7.53M	﹤0.01%	1257
2025 Q2	$11.8M	Buy	532,085 +125,655	+31%	+$2.63M	0.01%	1058
2025 Q1	$7.56M	Buy	406,430 +71,980	+22%	+$1.2M	0.01%	1150
2024 Q4	$4.43M	Buy	334,450 +97,200	+41%	+$2.35M	﹤0.01%	1294
2024 Q3	$7.95M	Buy	237,250 +206,750	+678%	+$7.06M	0.01%	1176
2024 Q2	$764K	Sell	30,500 -6,180	-17%	-$144K	﹤0.01%	1817
2024 Q1	$826K	Sell	36,680 -6,460	-15%	-$153K	﹤0.01%	1825
2023 Q4	$924K	Sell	43,140 -550	-1%	-$9.49K	﹤0.01%	1754
2023 Q3	$785K	Buy	+43,690	New	+$834K	﹤0.01%	1780
2022 Q3	–	Sell	-16,772	Closed	-$340K	–	2702
2022 Q2	$340K	Sell	16,772 -2,572	-13%	-$57K	﹤0.01%	2199
2022 Q1	$453K	Buy	+19,344	New	+$585K	﹤0.01%	2159
2020 Q2	–	Sell	-7,988	Closed	-$112K	–	2535
2020 Q1	$112K	Buy	+7,988	New	+$121K	﹤0.01%	2504
2019 Q4	–	Sell	-3,455	Closed	-$121K	–	2658
2019 Q3	$121K	Buy	+3,455	New	+$164K	﹤0.01%	2380